Celostátní screening Fabryho nemoci u pacientů s hypertrofickou kardiomyopatií v České republice
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27283933%3A_____%2F22%3A00011084" target="_blank" >RIV/27283933:_____/22:00011084 - isvavai.cz</a>
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14135" target="_blank" >https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14135</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/ehf2.14135" target="_blank" >10.1002/ehf2.14135</a>
Alternative languages
Result language
angličtina
Original language name
Celostátní screening Fabryho nemoci u pacientů s hypertrofickou kardiomyopatií v České republice
Original language description
Aims Fabry disease (FD) is a rare X-linked genetic disorder caused by a-galactosidase A (AGALA) deficiency. Whereas ‘classic‘ variant has multisystemic manifestation, the more recently described ‘later-onset‘ variant is characterized by predominant cardiac involvement that often mimics hypertrophic cardiomyopathy (HCM).
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
ESC HEART FAILURE
ISSN
2055-5822
e-ISSN
—
Volume of the periodical
9
Issue of the periodical within the volume
6
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
4160-4166
UT code for WoS article
000852286600001
EID of the result in the Scopus database
2-s2.0-85137713240